Journal
ACS NANO
Volume 7, Issue 11, Pages 9518-9525Publisher
AMER CHEMICAL SOC
DOI: 10.1021/nn405674m
Keywords
-
Categories
Funding
- NCI NIH HHS [R00CA153914, R00 CA153914] Funding Source: Medline
Ask authors/readers for more resources
Nanoparticles have recently emerged as a promising class of carriers for the co-delivery of multiple drugs. Combination therapies of small-molecule drugs are common in clinical practice, and it is anticipated that packaging into single macromolecular carriers will enable drug release in precisely balanced ratios and rates and in selectively targeted tissues and cells. This vast level of pharmacological control is intriguing, especially from the perspective of tailoring personalized treatments with maximized therapeutic synergy for individual patients. Here, we discuss promising formulations and opportunities to employ advanced screening tools and new animal models of disease that can improve chances for successful clinical translation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available